# Altering The Transition From Acute to Chronic Pain (ATTAC-Pain)

> **NCT03315533** · PHASE2 · COMPLETED · sponsor: **Rhode Island Hospital** · enrollment: 76 (actual)

## Conditions studied

- Musculoskeletal Pain

## Interventions

- **DRUG:** Duloxetine 30 milligrams (MG)
- **DRUG:** Duloxetine 60 milligrams (MG)
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03315533
- **Lead sponsor:** Rhode Island Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-19
- **Primary completion:** 2019-03-25
- **Final completion:** 2019-04-01
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2020-07-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03315533

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03315533, "Altering The Transition From Acute to Chronic Pain (ATTAC-Pain)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03315533. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*